Clinical and CT imaging features may help differentiate desmoid tumors from peritoneal disease in patients with resected colon cancer
Maria El Homsi(Memorial Sloan Kettering Cancer Center), Jennifer S. Golia Pernicka(Memorial Sloan Kettering Cancer Center), Iva Petkovska(Beth Israel Deaconess Medical Center), Stephanie Lobaugh(Memorial Sloan Kettering Cancer Center), Marinela Capanu(Memorial Sloan Kettering Cancer Center), Dina Hamdan(Icahn School of Medicine at Mount Sinai), Hala Khasawneh(The University of Texas Southwestern Medical Center), Mohammad Ali El Amine(Memorial Sloan Kettering Cancer Center), James L. Fuqua(Memorial Sloan Kettering Cancer Center), Lee Rodriguez(Memorial Sloan Kettering Cancer Center), Maria Widmar(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i> -Amplified Esophagogastric Cancer
|Cancer Discovery|2018|147
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: <i>Radiology</i> Scientific Expert Panel
|Radiology|2021|135
Rare germline mutations in<i>PALB2</i>and breast cancer risk: A population-based study
|Human Mutation|2012|86
MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response
|Clinical Colorectal Cancer|2021|81
Review of chest CT manifestations of COVID-19 infection
|European Journal of Radiology Open|2020|68